BridgeBio Pharma, Inc. (BBIO)
73.87
+1.17
(+1.61%)
USD |
NASDAQ |
Dec 11, 15:40
BridgeBio Pharma Free Cash Flow: -597.61M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Supernus Pharmaceuticals, Inc. | 70.75M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -109.57M |
| Cash from Investing (Quarterly) | 4.464M |
| Cash from Financing (Quarterly) | -0.894M |
| Free Cash Flow Per Share (Quarterly) | -0.5861 |
| Free Cash Flow to Equity (Quarterly) | -139.77M |
| Free Cash Flow to Firm (Quarterly) | -100.80M |
| Free Cash Flow Yield | -4.25% |